Growing Biomedical Research and Focus on Personalized Medicine to Aid Cell Isolation Market

The global cell isolation market accounted for $4.6 billion revenue in 2017, and it is expected to attain a CAGR of 18.8% during the forecast period (2018–2023). The demand for cell isolation products and services is increasing due to the rise in requirement for biopharmaceuticals, growing research activities in personalized medicine, and increasing government funding for research. Cell isolation is the separation of one or multiple types of cells from a heterogenous cell population.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market/report-sample

It has become an integral step in biological research, and routine diagnosis and treatment of certain diseases. Some cell types, such as blood cells, naturally exist in a separated form and thus can be isolated by employing centrifugation, whereas some others exist as solid tissues that require specific techniques to isolate the individual cell type. The global cell isolation market is witnessing growth owing to the rising demand for biopharmaceutical products derived from natural sources, such as plants, animals, and humans, that are easier to manufacture than conventional pharmaceuticals.

Biopharmaceuticals include monoclonal antibodies, recombinant proteins, and biosimilars, the manufacturing of which starts with cell separation and isolation techniques. Biopharmaceuticals are heavily employed to treat chronic conditions, mostly cancer, such as chronic myelogenous leukemia and melanoma. They are also used in various diagnostic assays, such as enzyme-linked immunosorbent assays (ELISA) and radioimmunoassay (RIA). Another major contributing factor to the growth of the cell isolation market is the increasing government funding in biomedical research.

Among these, the biomolecule isolation subdivision held the largest market share in terms of revenue in the historical period (2013–2017) due to the rising focus on biological compounds. The technique segment is further classified into surface marker, centrifugation, and filtration. During the forecast period, the surface marker classification is expected to be the fastest growing in the cell isolation market with a CAGR of 19.6%. The surface marker technique, because of its non-dependency on the cell density and size, is preferred more over filtration and centrifugation techniques.

Browse full report at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market

Some of the other key players operating in the cell isolation industry are Terumo Corporation, General Electric Company, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Danaher Corporation, Merck KGaA, Miltenyi Biotec GmbH, and Becton, Dickinson and Company.

Source: P&S Intelligence